Pseudoephedrine breastfeeding
Pro Research Analysisby 
Searched over 200M research papers for "pseudoephedrine breastfeeding"
Pseudoephedrine and Breastfeeding: Effects on Milk Production and Infant Exposure
Impact of Pseudoephedrine on Milk Production
Pseudoephedrine, a common decongestant, has been shown to significantly reduce milk production in lactating women. A study involving eight lactating women demonstrated that a single dose of 60 mg pseudoephedrine hydrochloride reduced milk volume by 24%, from an average of 784 ml/day during the placebo period to 623 ml/day during the pseudoephedrine period . This reduction in milk production is not attributed to changes in breast blood flow or temperature but may be linked to a slight, though not statistically significant, decrease in plasma prolactin levels .
Mechanism of Action: Prolactin Suppression
The reduction in milk production due to pseudoephedrine is likely related to its effect on prolactin secretion. Prolactin is a hormone crucial for milk synthesis, and its suppression can lead to decreased milk output. Although the change in prolactin levels was not significant in the study, the observed reduction in milk volume suggests that even minor alterations in prolactin can impact lactation .
Infant Exposure to Pseudoephedrine via Breast Milk
When lactating mothers take pseudoephedrine, the drug is excreted into breast milk. Research indicates that pseudoephedrine concentrations in breast milk are consistently higher than those in plasma, with the total amount of the drug in milk being two to three times greater than in plasma . However, the estimated infant dose of pseudoephedrine, assuming a maternal intake of 60 mg four times daily, is approximately 4.3% of the weight-adjusted maternal dose, which is considered unlikely to adversely affect the infant .
Safety and Recommendations for Breastfeeding Mothers
Despite the presence of pseudoephedrine in breast milk, the American Academy of Pediatrics (AAP) considers pseudoephedrine compatible with breastfeeding, suggesting it as a first-line choice for decongestant use in nursing mothers . However, it is recommended that breastfeeding mothers take medications immediately after breastfeeding, at the lowest effective dose, and for the shortest duration possible to minimize infant exposure .
Conclusion
Pseudoephedrine can significantly reduce milk production in lactating women, likely due to its effect on prolactin secretion. While the drug is excreted into breast milk at higher concentrations than in plasma, the estimated infant dose is relatively low and considered safe. Breastfeeding mothers should use pseudoephedrine cautiously, adhering to guidelines to minimize infant exposure. Further studies are needed to fully understand the safety and long-term effects of pseudoephedrine use during breastfeeding.
Sources and full results
Most relevant research papers on this topic